登录 | 注册    关注公众号  
微信公众号
搜索
 >  Antibody>gH&gL >GHL-MY2111

Monoclonal Anti-VZV gH & gL Antibody, Human IgG1 (4F12) (MALS verified)

抗体来源(Source)

Monoclonal Anti-VZV gH & gL Antibody, Human IgG1 (4F12) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.

克隆号(Clone)

4F12

种属(Species)

Mouse

亚型(Isotype)

Human IgG1 | Human Kappa

偶联(Conjugate)

Unconjugated

抗体类型(Antibody Type)

Recombinant Monoclonal

种属反应性(Reactivity)

Virus

免疫原(Immunogen)

Recombinant Varicella zoster virus (strain Oka vaccine) gH&gL Protein is expressed from human 293 cells.

特异性(Specificity)

Specifically recognizes VZV gH & gL.

应用(Application)

ApplicationRecommended Usage
ELISA0.1-63 ng/mL

纯度(Purity)

>95% as determined by SDS-PAGE.

>90% as determined by SEC-MALS.

纯化(Purification)

Protein A purified / Protein G purified

制剂(Formulation)

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

重构方法(Reconstitution)

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage)

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. -20°C to -70°C for 12 months in lyophilized state;
  2. -70°C for 3 months under sterile conditions after reconstitution.

质量管理控制体系(QMS)

  1. 质量管理体系(ISO, GMP)
  2. 质量优势
  3. 质控流程
 

电泳(SDS-PAGE)

gH&gL SDS-PAGE

Monoclonal Anti-VZV gH & gL Antibody, Human IgG1 (4F12) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

SEC-MALS

gH&gL SEC-MALS

The purity of Monoclonal Anti-VZV gH & gL Antibody, Human IgG1 (4F12) (Cat. No. GHL-MY2111) is more than 90% and the molecular weight of this protein is around 135-165 kDa verified by SEC-MALS.

Report

 

活性(Bioactivity)-ELISA

gH&gL ELISA

Immobilized Varicella zoster virus (strain Oka vaccine) gH&gL Protein, Twin-Strep Tag&His Tag (Cat. No. GHL-V5283) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-VZV gH & gL Antibody, Human IgG1 (4F12) (Cat. No. GHL-MY2111) with a linear range of 0.1-4 ng/mL (QC tested).

Protocol

 
评论(0)
 
ACRO质量管理体系
 
 

背景(Background)

Varicella-zoster virus (VZV) is the alphaherpesvirus that causes chicken pox (varicella) and shingles (zoster). As for all herpesviruses, VZV relies on a fusion complex comprised of three core glycoproteins, gB, gH and gL, required for entry of virions into host cells. VZV ORFs 37 and 60 encode gH (841aa; 118 kDa) and gL (160aa; 20 kDa), respectively, which are N- and O-linked glycosylated and form a heterodimer that is necessary for the activation of gB.

 

前沿进展

Bayesian spatiotemporal modelling and mapping of malaria risk among children under five years of age in Ghana
Takramah, Afrane, Aheto
BMC Infect Dis (2025) 25 (1), 430
Abstract: Malaria is a significant public health problem, particularly among children aged 6-59 months who bear the greatest burden of the disease. Malaria transmission is high and more pronounced in poor tropical and subtropical areas of the world. Climate change is positively correlated with the geographical distribution of malaria vectors. There is substantial evidence of spatial and temporal differences in under-five malaria risk. Thus, the study aimed to create intelligent maps of smooth relative risk of malaria in children under-5 years in Ghana that highlight high and low malaria burden in space and time to support malaria prevention, control, and elimination efforts.The study extracted and merged data on malaria among children aged 6-59 months from the 2014 Ghana Demographic and Health Surveys (GDHS), 2016 and 2019 Ghana Malaria Indicator Surveys (GMIS). The outcome variable of interest was the count of children aged 6-59 months with a positive test on the rapid diagnostic test (RDT) result. Bayesian Hierarchical spatiotemporal models were specified to estimate and map spatiotemporal variations in the relative risk of malaria. The existence of local clustering was assessed using the local indicator of spatial association (LISA), and the points were mapped to display significant local clusters, hotpot, and cold spot communities.The number of positive malaria cases in children aged 6-59 months decreased marginally from 946.7 (36.4%) in 2014 to 603.6 (22.9) in 2019 DHS survey periods. Smooth relative risk of malaria among children aged 6-59 months has consistently increased in the Northern and Eastern regions between 2014 and 2019. Socioeconomic and climatic factors such as household size [Posterior Mean: -0.198 (95% CrI: 3.52, 80.95)], rural area [Posterior Mean: 1.739 (95% CrI: 0.581, 2.867)], rainfall [Posterior Mean: 0.003 (95% CrI: 0.001, 0.005)], and maximum temperature [Posterior Mean: -1.069 (95% CrI: -2.135, -0.009)] were all shown as statistically significant predictors of malaria risk in children aged 6-59 months. Hot spot DHS clusters (enumeration areas) with a significantly high relative risk of malaria among children aged 6-59 months were repeatedly detected in the Ashanti region between 2014 and 2019.The findings of the study would provide policymakers with practical and insightful information for the equitable distribution of scarce health resources targeted at reducing the burden of malaria and its associated mortality among children under five years.© 2025. The Author(s).
Evaluating longitudinal cytomegalovirus-specific humoral immune responses and association with DNAemia risk in seropositive lung transplant recipients
Harnois, Barfield, Dennis et al
JHLT Open (2024) 5, 100113
Abstract: Cytomegalovirus (CMV) is the most common viral infection among lung transplant recipients and is associated with chronic lung allograft dysfunction. There is a need for better therapeutics as well as biomarkers to enable effective stratification of CMV seropositive patient risk for developing CMV DNAemia to inform prophylaxis duration.CMV-specific immunoglobulin G (IgG) binding and functional responses were evaluated in a discovery cohort of longitudinal plasma samples from 51 CMV seropositive human lung transplant recipients, collected as part of the clinical trials in organ transplantation (CTOT)-20 and CTOT-22 consortium studies. Pre-transplant plasma from an additional 43 CMV seropositive lung transplant recipients was evaluated as a validation cohort.In the discovery cohort with longitudinal samples, pre-transplant plasma IgG binding to CMV surface glycoproteins glycoprotein H (gH)/glycoprotein L (gL), gH/gL/glycoprotein O (gO), and pentameric complex, as well as neutralization of CMV in epithelial cells, is associated with increased risk of CMV DNAemia post-prophylaxis. However, these results were not confirmed by the validation cohort.While quantification of pre-transplant CMV-specific antibody responses showed association with DNAemia in the discovery cohort, additional clinical variables and/or known risk factors for CMV, such as patient CMV-specific T-cell responses, may need to be considered in combination with humoral immunity to effectively stratify risk of CMV DNAemia.© 2024 International Society for Heart and Lung Transplantation.
Herpes simplex virus 1 envelope glycoprotein C shields glycoprotein D to protect virions from entry-blocking antibodies
Hull, Pritchard, Nicola
J Virol (2025)
Abstract: Herpes simplex virus 1 (HSV-1) gD interaction with the host cell receptor nectin-1 triggers the membrane fusion cascade during viral entry. Potent neutralizing antibodies to gD prevent receptor-binding or prevent gD interaction with gH/gL critical for fusion. HSV has many strategies to evade host immune responses. We investigated the ability of virion envelope gC to protect envelope gD from antibody neutralization. HSV-1 lacking gC was more sensitive to neutralization by anti-gD monoclonal antibodies than a wild-type rescuant virus. gD in the HSV-1 gC-null viral envelope had enhanced reactivity to anti-gD antibodies compared to wild type. Soluble nectin-1 bound similar to HSV-1 particles regardless of the presence of gC in the envelope. However, entry of HSV-1 ΔgC was more sensitive to inhibition by soluble nectin-1 receptor. The viral membrane protein composition of HSV-1 ΔgC is equivalent to that of wild type, suggesting that the lack of gC is responsible for the increased reactivity of gD-specific antibodies and the consequent increased susceptibility to neutralization by those antibodies. Together, the results suggest that gC in the HSV-1 envelope shields both receptor-binding domains and gH/gL-interacting domains of gD from neutralizing antibodies, facilitating HSV cell entry.IMPORTANCEHSV-1 causes lifelong infections. There is no vaccine and no cure. Understanding HSV immune evasion strategies is an important goal. HSV-1 gC is a multi-functional envelope glycoprotein. This study suggests that virion gC physically shields neighboring gD from antibodies, including neutralizing monoclonal antibodies. This mechanism may allow HSV to escape immune detection, promoting HSV infection in the host.
Metabolic Engineering of E. coli for Enhanced Diols Production from Acetate
Ricci, Cen, Zu et al
ACS Synth Biol (2025)
Abstract: Effective employment of renewable carbon sources is highly demanded to develop sustainable biobased manufacturing. Here, we developed Escherichia coli strains to produce 2,3-butanediol and acetoin (collectively referred to as diols) using acetate as the sole carbon source by stepwise metabolic engineering. When tested in fed-batch experiments, the strain overexpressing the entire acetate utilization pathway was found to consume acetate at a 15% faster rate (0.78 ± 0.05 g/g/h) and to produce a 35% higher diol titer (1.16 ± 0.01 g/L) than the baseline diols-producing strain. Moreover, singularly overexpressing the genes encoding alternative acetate uptake pathways as well as alternative isoforms of genes in the malate-to-pyruvate pathway unveiled that leveraging ackA-pta and maeA is more effective in enhancing acetate consumption and diols production, compared to acs and maeB. Finally, the increased substrate consumption rate and diol production obtained in flask-based experiments were confirmed in bench-scale bioreactors operated in fed-batch mode. Consequently, the highest titer of 1.56 g/L achieved in this configuration increased by over 30% compared to the only other similar effort carried out so far.
Showing 1-4 of 1295 papers.
Powered by BizGenius
 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
gH&gL靶点信息
英文全称:Cytomegalovirus (CMV) envelope glycoprotein H
中文全称:巨细胞病毒包膜糖蛋白H
种类:
上市药物数量:0详情
临床药物数量:1详情
最高研发阶段:临床二期
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定